REG - Craneware plc - Vesting of Long Term Incentive Plan Award

CranewareAnnouncement

26/03/2020 16:35

RNS Number : 7713H
  
Craneware plc
  
26 March 2020
  
 

 
Craneware plc
("Craneware" or the "Company")
 
Vesting of Long Term Incentive Plan Award
 
26 March 2020 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 24 March 2020, under the terms of the Craneware plc Long Term Incentive Plan (2016) ("LTIP"), a conditional award of ordinary shares of 1p each in the Company ("Shares") which was granted to a Director of the Company on 24 March 2017, vested following the satisfaction of certain performance conditions.  
 
Craig Preston, a Director and CFO of the Company, received a net amount of 3,824 Shares, which is 0.01% of the issued share capital of the Company, from the vested LTIP award after deduction of the associated tax liabilities. No consideration was payable by Craig Preston to receive the Shares from this LTIP award. 
 
Following this transaction, Craig Preston holds 85,927 Shares which is 0.32% of the issued share capital of the Company.   
 
 
 
PDMR notification: Craig Preston
 
1.   Details of the Restricted Person / person closely associated with him or her
a) Name                                                            Craig Preston
 
2.   Reason for the notification
a) Position / status                                            CFO
b) Initial notification / Amendment                       Initial notification
 
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name                                                            Craneware plc
b) LEI                                                                213800O2CTJ1YFXNXG05
 
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 
a) Description of the financial instrument, type of
instrument                                                         Ordinary shares of 1p each in the capital of Craneware plc
 
b) Identification code                                         ISIN GB00B2425G68
 
c) Nature of the transaction                                Vesting of conditional share award under the Craneware plc
                                                                                    Long Term Incentive Plan (2016)
 
d) Price(s) and volume(s)                                   Volume(s) released from vested award 3,824, Price(s) £0
 
e) Aggregated information:
                                    i. Aggregated volume                Aggregate volume released 3,824
                                    ii. Price                                     Price(s) £0
 
f) Date of the transaction                                  2020-03-24
 
g) Place of the transaction                                 Outside a trading venue
 
 
 
For further information, please contact:
 




Craneware plc


Peel Hunt (NOMAD & Joint Broker)                


Investec Bank (Joint Broker)


Alma (Financial PR)




+44 (0)131 550 3100


+44 (0)20 7418 8900


+44 (0)20 7597 5970


+44 (0)203 405 0205




Keith Neilson, CEO


Dan Webster 


Patrick Robb


Caroline Forde 




Craig Preston, CFO


George Sellar
Andrew Clark


Sebastian Lawrence
Henry Reast


Hilary Buchanan
Helena Bogle




 


 


 


 




 


 


 


 




 
About Craneware
 
Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions. 
 
Learn more at www.craneware.com 
 
 
 
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHFLFFRVTIRFII